Use of Modified oligo-beta -(1,3)-glucans for Treating Diseases of the Immune System, oligo-beta -(1,3)-glucan-(1,3)-mannose, oligo-beta -(1,3)-glucan-(1,3)-mannitol and Derivatives Thereof, Methods for Preparing the Same and Drugs Containing Them - Archive ouverte HAL
Brevet Année : 2008

Use of Modified oligo-beta -(1,3)-glucans for Treating Diseases of the Immune System, oligo-beta -(1,3)-glucan-(1,3)-mannose, oligo-beta -(1,3)-glucan-(1,3)-mannitol and Derivatives Thereof, Methods for Preparing the Same and Drugs Containing Them

Domaines

Chimie organique

Valérie Chretien  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-00405824

Soumis le : mardi 21 juillet 2009-11:04:35

Dernière modification le : jeudi 17 octobre 2024-11:46:04

Fichier non déposé

Dates et versions

hal-00405824 , version 1 (21-07-2009)

Identifiants

  • HAL Id : hal-00405824 , version 1

Citer

Jean-Claude Yvin, Karine Descroix, Vincent Ferrières, Frank Jamois, Isabelle Laurent, et al.. Use of Modified oligo-beta -(1,3)-glucans for Treating Diseases of the Immune System, oligo-beta -(1,3)-glucan-(1,3)-mannose, oligo-beta -(1,3)-glucan-(1,3)-mannitol and Derivatives Thereof, Methods for Preparing the Same and Drugs Containing Them. Patent n° : 2008087340. 2008. ⟨hal-00405824⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-RENNES1 CNRS INSA-RENNES ISCR UR1-UFR-SPM ISCR-CORINT UNIV-RENNES INSA-GROUPE UR1-MMS
84 Consultations
0 Téléchargements

Partager

More